Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Applied Biochemistry and Biotechnology|May 29, 2000
Diversification and selection mechanisms for the production of protein repertoires: lessons from the immune systemM S Neuberger, J E Sale, S J Cumbers, et al.
Neuropharmacology|March 1, 1996
The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the ratL J Bristow, G P Cook, J C Gay, et al.
Biotechniques|September 20, 2002
Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/kappa or IgH/kappa/lambda translociS Magadán, M Valladares, E Suarez, et al.
Human Molecular Genetics|June 1, 1995
Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2J P Frippiat, S C Williams, I M Tomlinson, et al.
Neuropharmacology|May 24, 2003
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptorM R Guscott, E Egan, G P Cook, et al.
Bone Marrow Transplantation|November 11, 2008
Haematopoietic repopulating activity in human cord blood CD133+ quiescent cellsS A Boxall, G P Cook, D Pearce, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral testsL J Bristow, N Collinson, G P Cook, et al.
Clinical and Experimental Immunology|December 1, 2019
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastomaH J Close, L F Stead, J Nsengimana, et al.
Clinical and Experimental Immunology|December 4, 2014
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivoY M El-Sherbiny, T D Holmes, L F Wetherill, et al.
Pageof 11